Logo.jpg
Hepatitis C Drug Market To Reach USD 26.9 Billion By 2032 Report By DataHorizzon Research
February 02, 2024 06:40 ET | DataHorizzon Research
Fort Collins, Colorado, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The Hepatitis C Drug Market was valued at USD 20.8 Billion in 2022 and is anticipated to reach USD 26.9 Billion by 2032 at a CAGR of 2.7%. ...
Vantage Market Research.png
Hepatitis C Drug Market Size & Share to Surpass $56.5 Billion by 2030 | Vantage Market Research   
August 17, 2023 05:30 ET | Vantage Market Research
WASHINGTON, Aug. 17, 2023 (GLOBE NEWSWIRE) -- According to Vantage Market Research, the Global Hepatitis C Drug Market is estimated to be valued at USD 56.5 Billion by 2030 and is expected to...